[{"arm_notes": "", "treatment_id": null, "treatment_name": "1 (inactivated vaccine group):subjects were injected with 1 dose of inactivated COVID-19 vaccine (intramuscular injection) at the baseline (day 0);2 (recombinant protein vaccine group): the subjects were injected with 1 dose of recombinant protein vaccine (intramuscular injection) at the baseline (day 0);Control group:no intervention;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "1 (inactivated vaccine group):subjects were injected with 1 dose of inactivated COVID-19 vaccine (intramuscular injection) at the baseline (day 0)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "2 (recombinant protein vaccine group): the subjects were injected with 1 dose of recombinant protein vaccine (intramuscular injection) at the baseline (day 0)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control group:no intervention;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 643, "treatment_name": "Inactivated covid-19 vaccine", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 1154, "treatment_name": "Sars-cov-2 recombinant protein vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]